Integra LifeSciences Receives FDA Clearance for Cardiac Use of CUSA Clarity System

Integra LifeSciences has received FDA clearance for its CUSA Clarity Ultrasonic Surgical Aspirator System for use in cardiac surgery. The system is now approved for debridement of unwanted soft tissue during procedures such as valve replacement and repair. This expansion of indications marks a significant milestone for the company and its role in advanced cardiac care.